mongolian-massagelab · L3 - Massage · Chicago (Midwest)
Current Option Inventory (Units and GB are quarter-to-date rollups from 2026-04-01)
| Option | List | Sell | Effective Margin | Units QTD | GB QTD |
|---|---|---|---|---|---|
| 60 Minute Deep Tissue Or Swedish Massage | $79.00 | $73.00 | 0.0% | 0 | $0.00 |
| 120 Minute Deep Tissue Or Swedish Massage | $148.00 | $130.00 | 0.0% | 0 | $0.00 |
| 90 Minute Deep Tissue or Swedish Massage | $112.99 | $102.00 | 0.0% | 0 | $0.00 |
Activity Timeline (sorted newest first)
- 2025-08-03 Price change on 60 Minute Deep Tissue Or Swedish Massage — $65.00 → $73.00 analysed below
- 2025-08-02 Price change on 120 Minute Deep Tissue Or Swedish Massage — $115.00 → $130.00 analysed below
- 2025-05-03 Price change on 120 Minute Deep Tissue Or Swedish Massage — $89.00 → $115.00
- 2025-05-01 Margin change on 120 Minute Deep Tissue Or Swedish Massage — 30.0% → 26.3%
- 2025-04-29 Price change on 60 Minute Deep Tissue Or Swedish Massage — $49.00 → $65.00
3-Comparison — 60 Minute Deep Tissue Or Swedish Massage mongolian-massagelab
Price: $65.00 → $73.00
Windows: 30 days before change, 30 days after, same period last year, and peer-cohort change. "Δ vs Peer" is market-relative: deal's before→after change minus peers' before→after change. Positive = deal outperformed market. Negative = peers improved more than the deal did.
| Metric | Before 30d | After 30d | Δ vs Before | YoY | Δ vs YoY | Peer Δ (bf→after) | Δ vs Peer | Verdict |
|---|---|---|---|---|---|---|---|---|
| CVR | 6.0% | 4.4% | -26.2% | 0.0% | n/a | +2.7% | -29.0% | inconclusive |
| GB/UDV | $4.40 | $3.56 | -19.1% | $0.00 | n/a | +2.3% | -21.4% | |
| MVR/UDV | $0.72 | $0.68 | -5.7% | $0.00 | n/a | -148.1% | +142.4% |
3-Comparison — 120 Minute Deep Tissue Or Swedish Massage mongolian-massagelab
Price: $115.00 → $130.00
Windows: 30 days before change, 30 days after, same period last year, and peer-cohort change. "Δ vs Peer" is market-relative: deal's before→after change minus peers' before→after change. Positive = deal outperformed market. Negative = peers improved more than the deal did.
| Metric | Before 30d | After 30d | Δ vs Before | YoY | Δ vs YoY | Peer Δ (bf→after) | Δ vs Peer | Verdict |
|---|---|---|---|---|---|---|---|---|
| CVR | 3.0% | 1.3% | -56.6% | 0.0% | n/a | +20.8% | -77.3% | didnt work |
| GB/UDV | $3.77 | $1.85 | -50.9% | $0.00 | n/a | +13.2% | -64.0% | |
| MVR/UDV | $0.60 | $0.32 | -47.0% | $0.00 | n/a | +871.5% | -918.6% |
SF Context
Churn-threat classification from sales cases and tasks: sf data insufficient
No churn-threat keywords detected in recent cases or tasks.